Neonatal Unit Hopital Erasme
Brussels, Anderlecht, 1070, Belgium
NCT Number: NCT06198478
Immediate skin-to-skin contact (SSC) is already standard care for healthy term newborns, but its use for term or preterm newborns requiring admission to neonatal unit (NICU) with or without respiratory support is challenging. This study aimed to assess the safety and feasibility of SSC during the transfer of newborn infants, using a new purpose-built mobile shuttle care-station, called "Tandem".
A monocentric prospective observational study was conducted at the tertiary referral center of the Université libre de Bruxelles in Brussels, Belgium Infants born with a birth weight above 1500g were eligible. Following initial stabilization, infants were placed in SSC with one of their parents and transferred to the NICU using the Tandem.
Looking for future studies?
Notify MeAll sexes
Observational
Brussels, Anderlecht, 1070, Belgium
Prior to delivery, the trained neonatal team prepares both the Tandem and a transport incubator as a backup. Delayed umbilical cord clamping will be performed for at least one minute unless prompt resuscitation required. Then, infants will be stabilized on a resuscitation table following European Resuscitation Council guidelines, with applying electrodes for continous monitoring of heart rate, saturation and temperature. After initial stabilization respiratory support will be continued if needed using the Tandem's gas supply. In cases when, antibiotics or continuous IV glucose infusion are necessary, peripheral venous catheters will be placed before departure. In case of respiratory support, nasogastric tube will be insterted. Infants will be then transferred to the NICU under the supervision of a pediatric nurse and/or pediatrician with the Tandem in skin-to-skin position with either the mother or the father. Whenever possible, SSC will be continued for at least 120 minutes before placing the infant in an incubator. Blood glucose measurement will take place at least once during the procedure.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
s:
Exclusion criteria
Time frame: 0-2 hours of life
Rate of discontinuation of the skin-to-skin was measured
Time frame: 0-2 hours of life
Heart rate measured in bpm (considered normal range: 120-180 bpm )
Time frame: 0-2 hours of life
Saturation measured in % ( considered normal >92 %)
Time frame: 0-2 hours of life
Temperature measured in Celsius ( considered normal range: 36.5-37.5 C)
Time frame: 0-2 hours of life
Blood glucose level measured in mg/dL at least once during the first two hours of life (considered normal range: 30-100 mg/dL)
Time frame: 0-1 days of life
Parental and nursing satisfaction with skin-to-skin transfer via the Tandem from the delivery suite or the operating theater to the NICU were rated on a scale from 1 to 10 (10 being the most satisfied)
Time frame: 1 day (at discharge)
Exclusive breastfeeding rate at discharge
Erasme University Hospital
Other
Tandem: Skin-to-skin Transfer From the Delivery Room to the Neonatal Unit for Neonates Above 1500 g
Acronym: Tandem
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05737095
Female Urogenital Diseases and Pregnancy Complications, Lung Diseases
Dijon, France
View Trial DetailsNCT05036603
Atelectasis Neonatal, Bronchopulmonary Dysplasia
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT06569251
Distress Respiratory Syndrome, Female Urogenital Diseases and Pregnancy Complications
Tegucigalpa, Francisco Morazán Department, Honduras
View Trial DetailsNCT04944108
Female Urogenital Diseases and Pregnancy Complications, Lung Diseases
Brescia, Italy
View Trial Details